Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 30(12): 1436-48, 2011 Mar 24.
Article in English | MEDLINE | ID: mdl-21057535

ABSTRACT

Epithelial-to-mesenchymal transition (EMT) is a critical event in the progression toward cancer metastasis. The intermediate filament protein vimentin is an important marker of EMT and a requisite regulator of mesenchymal cell migration. However, it is not known how vimentin functionally contributes to cancer cell invasion. Here, we report that ectopic expression of oncogenic H-Ras-V12G and Slug induces vimentin expression and migration in pre-malignant breast epithelial cells. Conversely, vimentin expression is necessary for Slug- or H-Ras-V12G-induced EMT-associated migration. Furthermore, silencing of vimentin in breast epithelial cells results in specific changes in invasiveness-related gene expression including upregulation of RAB25 (small GTPase Rab25) and downregulation of AXL (receptor tyrosine kinase Axl), PLAU (plasminogen activator, urokinase) and ITGB4 (integrin ß4-subunit). Importantly, gene expression profiling analyses reveal that vimentin expression correlates positively/negatively with these genes also in multiple breast cancer cell lines and breast cancer patient samples. Focusing on the tyrosine kinase Axl, we show that induction of vimentin by EMT is associated with upregulation of Axl expression and that Axl enhances the migratory activity of pre-malignant breast epithelial cells. Using null and knock-down cells and overexpression models, we also show that regulation of breast cancer cell migration in two- and three-dimensional matrices by vimentin is Axl- dependent and that Axl functionally contributes to lung extravasation of breast cancer cells in mice. In conclusion, our data show that vimentin functionally contributes to EMT and is required for induction of Axl expression. Moreover, these results provide a molecular explanation for vimentin-dependent cancer cell migration during EMT by identifying Axl as a key proximal component in this process.


Subject(s)
Breast Neoplasms/pathology , Cell Movement , Epithelial-Mesenchymal Transition , Vimentin/metabolism , Animals , Breast Neoplasms/metabolism , Cell Line, Tumor , Female , Humans , Mice , Mice, Nude , NIH 3T3 Cells , Oncogene Protein p21(ras)/metabolism , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Snail Family Transcription Factors , Transcription Factors/metabolism , Vimentin/genetics , Xenograft Model Antitumor Assays , Axl Receptor Tyrosine Kinase
2.
FEBS Lett ; 495(1-2): 106-10, 2001 Apr 20.
Article in English | MEDLINE | ID: mdl-11322956

ABSTRACT

To study functional aspects of the exon 1 encoded region of the human immunodeficiency virus type 1 Rev protein, the viral Tev protein which exhibits low Rev activity but lacks the rev exon 1 encoded region was examined. Neither Rev-Tev heteromer complex formation nor inhibition of Rev by an export deficient Tev mutant was observed. Insertion of the rev exon 1 encoded region into the Tev mutant allowed it to oligomerize with Rev and act as a trans-dominant negative mutant. This showed that the exon 1 encoded region of Rev is essential for oligomerization and that oligomerization is a prerequisite for trans-dominant inhibition.


Subject(s)
Exons/genetics , Gene Products, rev/physiology , HIV-1/genetics , Suppression, Genetic/physiology , Animals , CHO Cells , COS Cells , Cricetinae , Fluorescent Antibody Technique , Gene Products, rev/antagonists & inhibitors , Genes, Dominant , Macromolecular Substances , Mutation , Protein Binding/physiology , Trans-Activators/genetics , Trans-Activators/metabolism , Transfection , Viral Fusion Proteins/genetics , Viral Fusion Proteins/metabolism , rev Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL
...